DK626089A - Middel til kontrolleret frigivelse af polypeptider - Google Patents

Middel til kontrolleret frigivelse af polypeptider Download PDF

Info

Publication number
DK626089A
DK626089A DK626089A DK626089A DK626089A DK 626089 A DK626089 A DK 626089A DK 626089 A DK626089 A DK 626089A DK 626089 A DK626089 A DK 626089A DK 626089 A DK626089 A DK 626089A
Authority
DK
Denmark
Prior art keywords
polypeptides
agent
controlled release
release
controlled
Prior art date
Application number
DK626089A
Other languages
English (en)
Other versions
DK626089D0 (da
Inventor
Michael Joseph Azain
Thomas Richard Kasser
Milton Jerome Sabacky
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DK626089D0 publication Critical patent/DK626089D0/da
Publication of DK626089A publication Critical patent/DK626089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK626089A 1988-12-13 1989-12-12 Middel til kontrolleret frigivelse af polypeptider DK626089A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28368588A 1988-12-13 1988-12-13
US42168189A 1989-10-18 1989-10-18

Publications (2)

Publication Number Publication Date
DK626089D0 DK626089D0 (da) 1989-12-12
DK626089A true DK626089A (da) 1990-06-14

Family

ID=26962178

Family Applications (1)

Application Number Title Priority Date Filing Date
DK626089A DK626089A (da) 1988-12-13 1989-12-12 Middel til kontrolleret frigivelse af polypeptider

Country Status (13)

Country Link
EP (1) EP0374120A3 (da)
JP (1) JPH02204418A (da)
KR (1) KR920005660B1 (da)
CN (1) CN1043631A (da)
AU (1) AU4617689A (da)
BR (1) BR8906435A (da)
CA (1) CA2005226A1 (da)
CZ (1) CZ702889A3 (da)
DK (1) DK626089A (da)
HU (1) HUT52395A (da)
IL (1) IL92662A0 (da)
NZ (1) NZ231730A (da)
PT (1) PT92548A (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5861166A (en) * 1991-03-12 1999-01-19 Alza Corporation Delivery device providing beneficial agent stability
WO1992016194A1 (en) * 1991-03-12 1992-10-01 Alza Corporation Space- and stability-efficient delivery device
DK136492D0 (da) * 1992-11-10 1992-11-10 Novo Nordisk As A pharmaceutical formulation
UA41502C2 (uk) * 1991-12-20 2001-09-17 Ново Нордіск А/С Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
US5849704A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
US5849700A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
US5198422A (en) * 1992-06-11 1993-03-30 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
BR9307361A (pt) * 1992-11-03 1999-06-01 Procter & Gamble Limpeza com tensoativos de cadeia curta
ZA949350B (en) 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5631225A (en) * 1994-10-13 1997-05-20 Novo Nordisk A/S Pharmaceutical formulation
US5654278A (en) * 1994-10-13 1997-08-05 Novo Nordisk A/S Composition and method comprising growth hormone and leucine
US5547696A (en) * 1994-10-13 1996-08-20 Novo Nordisk A/S Pharmaceutical formulation
US5705482A (en) * 1995-01-13 1998-01-06 Novo Nordisk A/S Pharmaceutical formulation
US5552385A (en) * 1995-06-05 1996-09-03 Novo Nordisk A/S Pharmaceutical formulation
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
ZA9711731B (en) * 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
EP0880969A1 (en) * 1997-05-28 1998-12-02 Applied Research Systems ARS Holdings N.V. Pharmaceutical compositions of peptides having low solubility in physiological medium
WO2000038652A1 (en) * 1998-12-23 2000-07-06 Amgen Inc. Polyol/oil suspensions for the sustained release of proteins
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
KR20090007504A (ko) * 2000-02-24 2009-01-16 몬산토 테크놀로지 엘엘씨 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
AU2001271491A1 (en) 2000-06-26 2002-01-08 Monsanto Technology Llc Non-aqueous surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
US20030089447A1 (en) * 2001-11-06 2003-05-15 Kenneth Molee Soft absorbent garment made with discretely coated elastic elements, and system and method for making a soft absorbent garment
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
JPS61500439A (ja) * 1983-11-21 1986-03-13 リ−ジエンツ　オヴ　ザ　ユニヴア−シテイ−　オヴ　ミネソタ 慢性的非経口ホルモン投与用緩衝化ポリオ−ル−ホルモン混合物
US4917685A (en) * 1986-05-16 1990-04-17 International Minerals & Chem. Corp. Delivery device for the administration of stabilized growth promoting hormones
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament

Also Published As

Publication number Publication date
EP0374120A3 (en) 1991-07-31
CN1043631A (zh) 1990-07-11
HUT52395A (en) 1990-07-28
JPH02204418A (ja) 1990-08-14
IL92662A0 (en) 1990-08-31
CZ702889A3 (en) 1995-01-18
DK626089D0 (da) 1989-12-12
AU4617689A (en) 1990-06-21
PT92548A (pt) 1990-06-29
KR910007542A (ko) 1991-05-30
NZ231730A (en) 1991-10-25
BR8906435A (pt) 1990-08-28
CA2005226A1 (en) 1990-06-13
KR920005660B1 (ko) 1992-07-13
EP0374120A2 (en) 1990-06-20
HU896513D0 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
DK626089D0 (da) Middel til kontrolleret frigivelse af polypeptider
DK89091A (da) Fremgangsmaade til fremstilling af vitamin-d-forbindelser
DK230789D0 (da) Fremgangsmaade til fremstilling af cytidinderivater
DK453789D0 (da) Fremgangsmaade til paavirkning af azopigmenters triboelektriske effekt
DK461589D0 (da) Uv-haerdelig materialer til fremstilling af trykte kredsloeb
DK468888D0 (da) Fremgangsmaade til fresmtilling af keramiske pulvere
DK121591D0 (da) Fremgangsmaade til fremstilling af gelatinefolier
DK250689D0 (da) Fremgangsmaade til fremstilling af napthalenderivater
DK349689A (da) Fremgangsmaade til fremstilling af keramiske formdele
DK30489A (da) Fremgangsmaade til fremstilling af pyranderivater
DK200489A (da) Fremgangsmaade til fremstilling af polypeptider
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK315789A (da) Fremgangsmaade til fremstilling af halogenerede sulfoner
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK589089A (da) Anvendelse af benzomorphaner til cytoprotektion
DK113189A (da) Fremgangsmaade til fremstilling af pyridinderivater
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK356789A (da) Fremgangsmaade til hydrogenolyse af halogenerede aromatiske forbindelser
DK19889A (da) Fremgangsmaade til fremstilling af polypeptider
DK293589D0 (da) Fremgangsmaade til fremstiling af lactolderivater
DK599689A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK162789D0 (da) Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
DK127589D0 (da) Fremgangsmaade til fremstilling af phenolskumstoffer
DK629089D0 (da) Fremgangsmaade til fremstilling af arylacetotrifluorethoxyphenylketoner
DK322688D0 (da) Profylaktisk middel til kontrol af koenssydomme

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment